Randomised clinical trial: Daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms Academic Article uri icon

Overview

MeSH Major

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Esomeprazole
  • Gastroesophageal Reflux
  • Proton Pump Inhibitors

abstract

  • Pantoprazole-Mg 40 mg was at least as effective as esomeprazole 40 mg for complete remission and the mucosal healing rate was high. Symptom relief with pantoprazole-Mg continued to improve from 4 to 8 weeks and was greater than that with esomeprazole at week 8, suggesting an extended period of treatment effect (ClinicalTrials.gov identifier: NCT01132638).

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/apt.12540

PubMed ID

  • 24299323

Additional Document Info

start page

  • 47

end page

  • 56

volume

  • 39

number

  • 1